Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11570210 | 0.95 | HSD17B10 (0.46) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL3310904 | 0.82 | THRB (0.53) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL28381521 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL1269971 | 0.80 | — | — | |
| SCHEMBL21518308 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL31509564 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL29001937 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL17124654 | 0.77 | HSD17B10 (0.48) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL10726944 | 0.76 | ALDH1A1 (0.59) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL18092839 | 0.76 | HSD17B10 (0.41) | ALDH1A1TSHRCHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1752463-B1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | SAN APRO LTD (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-7709598-B2 | Fluorinated alkyl fluorophoshoric acid salts of onium and transition metal complex | SAN-APRO LIMITED (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | SAN-APRO LIMITED (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1106639-B1 | PHOTOCURABLE COMPOSITION CONTAINING IODONIUM SALT COMPOUND | NIPPON SODA CO (JP) | 2007-08-29 | — | — | EP | disclosed |
| EP-1752463-A1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | San-Apro Limited (JP) | 2007-02-14 | — | — | EP | disclosed |
| US-6558871-B1 | Photopolymerization initiator comprising at least one of diaryliodonium salt | NIPPON SODA CO. LTD. (JP) | 2003-05-06 | — | — | US | disclosed |
| EP-1106639-A1 | PHOTOCURABLE COMPOSITION CONTAINING IODONIUM SALT COMPOUND | NIPPON SODA CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |
| EP-0143380-B1 | PHOTORESIST COMPOSITION | CIBA-GEIGY AG (CH) | 1989-02-15 | — | — | EP | disclosed |
| EP-0143380-A2 | Photoresist composition | CIBA-GEIGY AG (CH) | 1985-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | AS3MT, TTR, PFAS | ALDH1A1 3745/4885TSHR 753/4885CHRM5 3105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.